Estimating the number of people who inject drugs in Australia
- PMID: 28962604
- PMCID: PMC5622458
- DOI: 10.1186/s12889-017-4785-7
Estimating the number of people who inject drugs in Australia
Abstract
Background: Injecting drug use is associated with considerable morbidity and mortality. Estimates of the size of the population of people who inject drugs are critical to inform service planning and estimate disease burden due to injecting drug use. We aimed to estimate the size of the population of people who inject drugs in Australia.
Methods: We applied a multiplier method which used benchmark data (number of people in opioid substitution therapy (OST) on a snapshot day in 2014) and multiplied it by a factor derived from the prevalence of current OST among people who inject drugs participating in the Australian Needle and Syringe Program Survey in 2014. Estimates of the total population of people who inject drugs were calculated in each state and territory and summed to produce a national estimate. We used the sex and age group distribution seen in datasets relating to people who inject drugs to derive sex- and age-stratified estimates, and calculated prevalence per 1000 population.
Results: Between 68,000 and 118,000 people aged 15-64 years inject drugs in Australia. The population prevalence of injecting drug use was 6.0 (lower and upper uncertainty intervals of 4.3 and 7.6) per 1000 people aged 15-64 years. Injecting drug use was more common among men than women, and most common among those aged 35-44 years. Comparison of expected drug-related deaths based on these estimates to actual deaths suggest that these figures may be underestimates.
Conclusions: These are the first indirect prevalence estimates of injecting drug use in Australia in over a decade. This work has identified that there are limited data available to inform estimates of this population. These estimates can be used as a basis for further work estimating injecting drug use in Australia.
Keywords: Epidemiology; Indirect prevalence estimation; Multiplier methods; People who inject drugs; Population size.
Conflict of interest statement
Ethics approval and consent to participate
This study was approved by the University of New South Wales Human Research Ethics Panel (ref. HC15606). Consent for data use was not obtained as only aggregate data were used in the analysis; no identifiable or potentially identifiable data were accessed.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Similar articles
-
Estimating the number of people who inject drugs and syringe coverage in Australia, 2005-2016.Drug Alcohol Depend. 2019 Apr 1;197:108-114. doi: 10.1016/j.drugalcdep.2018.11.033. Epub 2019 Feb 13. Drug Alcohol Depend. 2019. PMID: 30802734
-
Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review.Lancet Glob Health. 2023 May;11(5):e659-e672. doi: 10.1016/S2214-109X(23)00057-8. Epub 2023 Mar 27. Lancet Glob Health. 2023. PMID: 36996857
-
Prevalence of high-risk drug use and coverage of opioid substitution treatment and needle and syringe programs in Lithuania in 2015-2016: A multi-method estimation study.J Subst Abuse Treat. 2021 Mar;122:108229. doi: 10.1016/j.jsat.2020.108229. Epub 2020 Dec 3. J Subst Abuse Treat. 2021. PMID: 33509418
-
HIV prevalence, related risk behaviors, and correlates of HIV infection among people who use drugs in Cambodia.BMC Infect Dis. 2018 Nov 13;18(1):562. doi: 10.1186/s12879-018-3472-3. BMC Infect Dis. 2018. PMID: 30424727 Free PMC article.
-
Prevalence of injecting drug use and HIV, hepatitis B, and hepatitis C in people who inject drugs in the Eastern Mediterranean region: a systematic review and meta-analysis.Lancet Glob Health. 2023 Aug;11(8):e1225-e1237. doi: 10.1016/S2214-109X(23)00267-X. Lancet Glob Health. 2023. PMID: 37474230
Cited by
-
"No-one just does drugs during business hours!": evaluation of a 24/7 primary needle and syringe program in St Kilda, Australia.Harm Reduct J. 2024 Feb 24;21(1):51. doi: 10.1186/s12954-024-00960-9. Harm Reduct J. 2024. PMID: 38402389 Free PMC article.
-
Use of Population-Based Surveys for Estimating the Population Size of Persons Who Inject Drugs in the United States.J Infect Dis. 2020 Sep 2;222(Suppl 5):S218-S229. doi: 10.1093/infdis/jiaa318. J Infect Dis. 2020. PMID: 32877538 Free PMC article.
-
Harm Minimisation Drug Policy Implementation Qualities: Their Efficacy with Australian Needle and Syringe Program Providers and People Who Inject Drugs.Healthcare (Basel). 2022 Apr 22;10(5):781. doi: 10.3390/healthcare10050781. Healthcare (Basel). 2022. PMID: 35627918 Free PMC article.
-
Timely Hepatitis C RNA Testing and Treatment in the Era of Direct-Acting Antiviral Therapy among People with Hepatitis C in New South Wales, Australia.Viruses. 2022 Jul 8;14(7):1496. doi: 10.3390/v14071496. Viruses. 2022. PMID: 35891474 Free PMC article.
-
Changing age profile and incidence of injecting drug use initiation among people in Australia who inject drugs: evidence from two national repeated cross-sectional studies.Lancet Reg Health West Pac. 2025 Apr 17;57:101548. doi: 10.1016/j.lanwpc.2025.101548. eCollection 2025 Apr. Lancet Reg Health West Pac. 2025. PMID: 40297570 Free PMC article.
References
-
- Degenhardt L, Charlson F, Stanaway J, Larney S, Alexander LT, Hickman M, Cowie B, Hall WD, Strang J, Whiteford H, et al. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013. Lancet Infect Dis. 2016;16(12):1385–1398. doi: 10.1016/S1473-3099(16)30325-5. - DOI - PubMed
-
- World Health Organization . WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. Geneva: World Health Organization; 2012.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources